Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Eleusis to Debut as the World’s First Legal Luxury Psychedelic Immersion

February 3, 2026

Alpha Modus Financial Services Selects ACI Worldwide to Power National-Scale Remittance and Bill Pay Infrastructure for Alpha Cash

February 3, 2026

Byte Exchange Announces Blockchain Infrastructure Ready for $16 Trillion Real-World Asset Era

February 3, 2026

Corcentric Partners with Workato to Expand Integration Capabilities for Procurement and Finance Teams

February 3, 2026

Safe Project Reports $10M Revenue, Targets Break-Even and $100M ARR Path by 2030

February 3, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » United States $5.43 Bn Blood Glucose Monitoring Devices Market, Competition, Forecast and Opportunities, 2028F
Press Release

United States $5.43 Bn Blood Glucose Monitoring Devices Market, Competition, Forecast and Opportunities, 2028F

By News RoomDecember 12, 20234 Mins Read
United States .43 Bn Blood Glucose Monitoring Devices Market, Competition, Forecast and Opportunities, 2028F
Share
Facebook Twitter LinkedIn Pinterest Email
United States .43 Bn Blood Glucose Monitoring Devices Market, Competition, Forecast and Opportunities, 2028F

Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) — The “United States Blood Glucose Monitoring Devices Market, Competition, Forecast and Opportunities, 2018-2028” report has been added to ResearchAndMarkets.com’s offering.

United States Blood Glucose Monitoring Devices Market has valued at USD 3.47 Billion in 2022 and is anticipated to project steady growth in the forecast period with a CAGR of 7.92% through 2028.

While the most common type of device is the glucose meter, continuous glucose monitoring (CGM) systems have gained popularity due to their ability to provide real-time, continuous sugar level readings around the clock. CGM systems offer a comprehensive and detailed view of blood sugar fluctuations, empowering individuals to make informed decisions about their diabetes management and overall well-being.

Growing Diabetes Prevalence:

  • Diabetes prevalence in the US is increasing, driving demand for blood glucose monitoring devices.
  • 10.5% of the population (34.2 million Americans) had diabetes in 2018.
  • Awareness of diabetes management importance boosts device demand.
  • Advancements in technology lead to user-friendly glucose monitoring devices.
  • The market is projected to reach $10.5 billion by 2025.
  • Availability of insurance coverage and non-invasive monitoring tech contribute to growth.

Increasing Geriatric Population:

  • The rising elderly population in the US increases the need for blood glucose monitoring devices.
  • Elderly individuals are more susceptible to diabetes, especially type 2.
  • Nearly 26.8% of adults aged 65+ have diabetes.
  • Geriatric awareness of diabetes management and non-invasive devices drive demand.
  • Demand for accessible, reliable solutions for diabetes management is pressing.

New Product Launches:

  • Launching new products significantly impacts the demand for blood glucose monitoring devices.
  • Technological innovations lead to compact, user-friendly, and accurate devices.
  • Continuous Glucose Monitoring Systems (CGMS) offer real-time monitoring and enhance user experience.
  • Increased awareness through marketing efforts drives device adoption.
  • New products and awareness contribute to better diabetes management.

Growing Advancements in Technologies:

  • Advancements in technology, like AI and IoT, drive demand for monitoring devices.
  • Advanced devices offer continuous monitoring, real-time data sharing, and personalized insights.
  • Integration of glucose data with other health information promotes comprehensive diabetes management.
  • Telemedicine and digital health platforms improve accessibility and quality of diabetes care.
  • Digitalization in healthcare shapes the future of diabetes management.

Key Market Challenges:

  • Large inaccuracies in devices decrease consumer trust and demand.
  • Inaccurate results can lead to improper diabetes management and health complications.
  • Stringent regulatory scrutiny, including FDA oversight, affects consumer confidence.
  • Manufacturers must focus on enhancing device accuracy to regain trust.

Intense Competition Among Competitors:

  • The competitive landscape is marked by intense rivalry, with multiple market players.
  • Price wars, product feature improvements, and innovation drive competition.
  • Confusion among consumers and aggressive marketing can reduce overall demand.
  • Balanced competition that fosters sustainable growth and customer satisfaction is needed.

Key Market Trends:

  • Growing adoption of smartwatch-based applications revolutionizes diabetes management.
  • Smartwatches offer convenience and real-time data monitoring.
  • Integration of blood glucose monitoring in smartwatches drives adoption.
  • The trend empowers individuals for proactive and personalized diabetes management.

Emergence of Needle-Free Devices:

  • Needle-free devices eliminate discomfort and inconvenience, driving demand.
  • Easier and pain-free monitoring enhances patient safety.
  • Needle-free devices align with the preference for non-invasive healthcare tech.
  • Increased prevalence of diabetes necessitates efficient monitoring solutions.

Segmental Insights:

  • Continuous Glucose Monitoring (CGM) devices are transforming the market with convenience and technology.
  • CGMs provide real-time glucose readings, enhancing patient empowerment and control.
  • Integration with smartphone apps further improves user experience.
  • Type 2 Diabetes dominates the market due to its increasing prevalence.
  • Blood glucose monitoring devices enable effective management of Type 2 Diabetes.
  • The emphasis on preventive healthcare and awareness drives demand.
  • The Western region of the US leads in diabetes management due to a high prevalence, awareness, and presence of key market players.

Key Attributes:

Report Attribute Details
No. of Pages 84
Forecast Period 2022 – 2028
Estimated Market Value (USD) in 2022 $3.47 Billion
Forecasted Market Value (USD) by 2028 $5.43 Billion
Compound Annual Growth Rate 7.9%
Regions Covered United States

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the United States Blood Glucose Monitoring Devices Market.

  • Abbott Laboratories Inc
  • Medtronic plc
  • Roche Diagnostics Corporation
  • DexCom, Inc.
  • B. Braun Medical Inc.
  • Becton, Dickinson and Company
  • Sanofi-Aventis U.S. LLC
  • Insulet Corporation
  • Nipro Medical Corporation
  • Terumo Medical Corporation

Report Scope:

United States Blood Glucose Monitoring Devices Market, By Product:

  • Self-Blood Glucose Monitoring Devices
  • Continuous Glucose Monitoring Devices

United States Blood Glucose Monitoring Devices Market, By Application:

  • Type 2 Diabetes
  • Type 1 Diabetes
  • Gestational Diabetes

United States Blood Glucose Monitoring Devices Market, By End User:

  • Home Care Setting
  • Hospital & Clinics
  • Others

United States Blood Glucose Monitoring Devices Market, By Region:

  • Northeast Region
  • Midwest Region
  • West Region
  • South Region

For more information about this report visit https://www.researchandmarkets.com/r/vo35j6

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • U.S. Blood Glucose Monitoring Devices Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Eleusis to Debut as the World’s First Legal Luxury Psychedelic Immersion

Alpha Modus Financial Services Selects ACI Worldwide to Power National-Scale Remittance and Bill Pay Infrastructure for Alpha Cash

Byte Exchange Announces Blockchain Infrastructure Ready for $16 Trillion Real-World Asset Era

Corcentric Partners with Workato to Expand Integration Capabilities for Procurement and Finance Teams

Safe Project Reports $10M Revenue, Targets Break-Even and $100M ARR Path by 2030

Take the wheel of the latest commercial EVs and high-tech work trucks at Work Truck Week 2026 Ride & Drive

Kean University President Lamont O. Repollet and Distinguished Professor Robin Landa Explore Values-Based Leadership in New Book

Copper Mountain Technologies Advances Global Production Strategy with Expanded Manufacturing Operations in Cyprus

New Crypto Mutuum Finance (MUTM) Update: What the V1 Protocol Launch Means for Investors

Editors Picks

Alpha Modus Financial Services Selects ACI Worldwide to Power National-Scale Remittance and Bill Pay Infrastructure for Alpha Cash

February 3, 2026

Byte Exchange Announces Blockchain Infrastructure Ready for $16 Trillion Real-World Asset Era

February 3, 2026

Corcentric Partners with Workato to Expand Integration Capabilities for Procurement and Finance Teams

February 3, 2026

Safe Project Reports $10M Revenue, Targets Break-Even and $100M ARR Path by 2030

February 3, 2026

Subscribe to News

Get the latest Canada news and updates directly to your inbox.

Latest News

Take the wheel of the latest commercial EVs and high-tech work trucks at Work Truck Week 2026 Ride & Drive

February 3, 2026

Kean University President Lamont O. Repollet and Distinguished Professor Robin Landa Explore Values-Based Leadership in New Book

February 3, 2026

Infectious disease data safe from cyberattack, Ontario public health unit says

February 3, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version